The Combination of Alisporivir plus an NS5A Inhibitor Provides Additive to Synergistic Anti-Hepatitis C Virus Activity without Detectable Cross-ResistanceUdayan Chatterji, Philippe Gallay, James Baugh et al.|Antimicrobial Agents and Chemotherapy|2014Cited by 37